The EBV glycoprotein gp340 was initially used as a prototype subunit vaccine that offered protection against EBV infection or EBV-induced lymphomas in cottontop tamarins, but the gp340-specific antibody was unable to neutralize EBV in vitro [112,113,114]. This evidence concerns the gene DMBT1 and lymphoma.